How Tentarix's US$35m capital raise is set to boost business for Vancouver's ITS

📆 07/09/2023 09.45.00
📰 PGCitizen

⏱ Reading Time:
30 sec. here
2 min. at publisher
📊 Quality Score:
News: 15%
Publisher: 51%

Indonesia Berita Berita

Indonesia Berita Terbaru,Indonesia Berita utama

Vancouver's Innovative Targeting Solutions partners with San-Diego-based Tentarix to make drugs

San Diego-based Tentarix Biotherapeutics' US$35-million Series B financing is good news for Vancouver's Innovative Targetting Solutions , with which it shares executives and co-founders.

ITS employs 14 staff who work out of the company's 5,000-square-foot head office and lab on Virtual Way in East Vancouver. ITS is not hiring at the moment, Kang said, but he does expect the company's workload to expand. Tentarix today announced that its new US$35-million financing was led by Amplitude Ventures with participation from Gilead Sciences, Inc. , and founding investors Versant Ventures and Samsara BioCapital.

Tentarix in 2021 raised US$50 million in a financing round co-led by two San Francisco-based companies: Versant and Samsara BioCapital.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Tulis Komentar

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

How Tentarix's US$35m capital raise is set to boost business for Vancouver's ITSVancouver's Innovative Targeting Solutions partners with San-Diego-based Tentarix to make drugs
Sumber: BurnabyNOW_News - 🏆 14. / 77 Baca lebih lajut »